Shi et al. evaluated the anti-tumor efficacy of an IT-implanted supramolecular polypeptide hydrogel co-loaded with an anti-PD-L1 mAb and doxorubicin (Dox) in mice with B16 tumors. The gene discussed is CD274; the disease is neoplasm.